News
Portfolio manager shows faith and patience in small caps
In the lead up to this week’s The Insider: Meet the Fund Manager, Graeme Carson from Cyan Investment Management sat down with Reach Markets to provide a bit of information about his investment strategy, industries of interest and view on the market.
Two sides of the trillion dollar coin
Some call it the ‘least bad option’, some a ‘dumb idea that won’t go away’. But perhaps it was beloved fictional character Homer J. Simpson who summed it up perfectly when he said, “Ooo a trillion dollar bill, that’s a spicy meatball!”
Topped up with cash, Prescient presses on in US$280 billion industry
COVID may have dominated headlines in 2020 causing at least 3 million deaths as reported by the World Health Organisation, but in the same year nearly 10 million lives were lost to a much deadlier adversary – cancer. Fighting back is clinical-stage biotech company Prescient Therapeutics (ASX: PTX).
Note from the MD: Markets bullish as economic data points to lower terminal rate
Just a day away from another Fed rate hike decision, US markets have surged after fourth quarter inflation data showed labour costs had increased at their slowest pace in a year. The S&P 500 stacked on almost 1.5%, the Nasdaq over 1.6%. Data released yesterday showed demand for US crude and petroleum products also rose in November, which combined with a slightly weakened US dollar allowed Brent oil to finish up 1% last night.
Power of Australian sun yet to be harnessed
The largest solar power project in Australia’s history has hit a brick wall, with two of Australia’s richest billionaires now battling it out in a high profile rivalry that is forming the debate on what is the most viable form of renewable energy.
Pioneering biotech at the heart of US$2.5 billion addressable market
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In July, Horizon 3 Healthcare’s Matt McNamara selected EBR Systems as one of his favourite stocks, pointing to the company’s patented wireless…
A significant milestone with large scale poultry producer Perdue Farms
meldCX’s AI testing results produced 99.25% accuracy, which is in excess of their target accuracy baseline with the client and is set to help the largest poultry producer in the US reduce waste, assist with employee overheads and help ease the restraints of staffing shortages. This is another example of why meldCX’s AI platform is being adopted by some of the largest companies in the world.
Note from the MD: Markets and commodities press ahead while power retreats
The ASX 200 is now less than 2% away from it’s all time high, after stacking on around 7% January gains in a strong start to the year. Traders will be eagerly watching fourth quarter CPI data that gets released today at 11:30am (AEDT), with the RBA forecasting 6.5%. The VIX continues to hover around 19-20 while all US index’s ended the day only marginally different Monday.
Hold the line, bubs aren’t always on time
Guess what’s not being made in China. Enough babies. China has been losing ground to its neighbour just over the Himalayas, India in terms of population growth. Chinese authorities in Hong Kong took this as a cue to contact recently married women, inquiring whether they expect to be expecting.
Mining capex to drop as viability of projects questioned
Pandemic era feasibility studies that have fast become outdated are driving a forecast 11% reduction in capital expenditure on mining projects during 2023. It is estimated that capex peaked in 2012 at US$164.1 billion, largely driven by iron and gold project development which accounted for 58% of this expenditure. It reached a recent low of $65.8 billion in 2016, with gold and iron ore making up almost two thirds of the annual decrease.
Small businesses chasing funds in tighter credit market
A culmination of rising interest rates and the maturation of cheap fixed interest loans has rapidly changed the small to medium business finance sector.
High expectations for Germany as global cannabis markets light up
Over the past few decades, the world has grown savvy to the benefits of cannabis with the industry reporting in October 2021 that at least 30 countries had legalised its medicinal use creating a market estimated to be worth $80 billion in 2024.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.